NEWS AND RESOURCES

Stay up to date

Please visit this page for the latest announcements and events from ZielBio.
June 02, 2023 | Press Releases

ZielBio to Present Interim Findings from its Phase 1/2, First-in-Human Trial of ZB131 at 2023 ASCO Annual Meeting

READ MORE
April 17, 2023 | Press Releases

ZielBio to Present New Research on the Utility of Cancer-Specific Plectin (CSP) and ZB131 in Antibody-Drug Conjugates at AACR Annual Meeting 2023

READ MORE
January 03, 2023 | Press Releases

ZielBio Appoints Alan Bash CEO as Company Advances Oncology Therapeutics

READ MORE
December 23, 2022 | Press Releases

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Pancreatic Cancer

READ MORE